Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER
MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market for our Common Stock
Our common stock is quoted on the NYSE American under the symbol “PLAG”.
Approximate Number of Holders of Our Common Stock
As of March 29, 2022, there were 346 stockholders of record of our
common stock. This does not include the holders whose shares are held in a depository trust in “street” name.
Dividend
We have not declared or paid cash dividends other than the payment
of a dividend in April 2007 in connection with our reverse merger. Any future decisions regarding dividends will be made by our Board
of Directors. We currently intend to retain and use any future earnings for the development and expansion of our business and do not
anticipate paying any cash dividends in the foreseeable future.
Issuances of Unregistered Securities
On May 9, 2019, we and Shanghai Xunyang entered into a share exchange
agreement with Xianning Bozhuang and each of the original shareholders of Xianning Bozhuang. Such transaction closed on May 14, 2019.
Pursuant to the share exchange agreement, we issued an aggregate of 1,080,000 shares of common stock of the Company to the Sellers in
exchange for the transfer of all of the equity interest of Xianning Bozhuang to Shanghai Xunyang.
On June 17, 2019, the Company entered into a securities purchase agreement,
pursuant to which five individuals residing in the PRC agreed to purchase an aggregate of 1,300,000 shares of the Company’s common
stock, par value $0.001 per share, for an aggregate purchase price of $5,460,000, representing a purchase price of $4.20 per share. The
transaction closed on June 19, 2019.
On January 26, 2021, the Company entered into a securities purchase
agreement, pursuant to which three individuals residing in the PRC agreed to purchase an aggregate of 2,700,000 shares of the Company’s
common stock, par value $0.001 per share, for an aggregate purchase price of $6,750,000, representing a purchase price of $2.50 per share.
The transaction closed on January 29, 2021.
On March 9, 2021, the Company entered into a share exchange agreement
with Jilin Chuangyuan and each of the original shareholders of Jilin Chuangyuan. Pursuant to the share exchange agreement, we issued
an aggregate of 3,300,000 shares of common stock of the Company to the Sellers in exchange for the transfer of 75% of the equity interest
of Jilin Chuangyuan.
On April 24, 2021, the Company entered into a securities purchase
agreement, pursuant to which three individuals residing in the PRC agreed to purchase an aggregate of 4,000,000 shares of the Company’s
common stock, par value $0.001 per share, for an aggregate purchase price of $7,600,000, representing a purchase price of $1.90 per share.
The transaction closed on May 20, 2021.
On July 15, 2021, the Company entered into a share exchange agreement
with Anhui Ansheng and each of the original shareholders of Anhui Ansheng. Pursuant to the share exchange agreement, we issued an aggregate
of 4,800,000 shares of common stock of the Company to the Sellers in exchange for the transfer of 66% of the equity interest of Anhui
Ansheng.
On December 9, 2021, the Company entered into a
share exchange agreement with Shandong Yunchu and each of the original shareholders of Shandong Yunchu. Pursuant to the share exchange
agreement, we issued an aggregate of 5,800,000 shares of common stock of the Company to the Sellers in exchange for the transfer of all
of the equity interest of Shandong Yunchu.
Securities Authorized for Issuance under Equity Compensation
Plans
We have issue 870,000 shares under our equity compensation plan in
the fiscal year of 2021.
19
ITEM 6. RESERVED
Not applicable.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.